Sarepta Therapeutics, Inc. Gains 34.98%
Wed, Mar 25, 2026 at 07:25 PM
Sarepta Therapeutics, Inc. (SRPT:NASDAQ) soared at $23.77, representing a gain of 35%. On Wed, Mar 25, 2026, SRPT:NASDAQ hit a New 2-Week High of $23.77. The stock appeared on our News Catalysts scanner on Wed, Mar 25, 2026 at 02:02 PM in the 'MISCELLANEOUS' category. From Wed, Mar 11, 2026, the stock recorded 60.00% Up Days and 63.64% Green Days
The stock spiked on Wed, Oct 08, 2025 at $25.32 with a volume of 10M+.
About Sarepta Therapeutics, Inc. (SRPT:NASDAQ)
Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 1010%
- Next Technology Holding Inc. (NXTT:NASDAQ), 77%
- MKDWELL Tech Inc. (MKDW:NASDAQ), 70.36%
- Real Messenger Corporation (RMSG:NASDAQ), 70.03%
- iTonic Holdings Ltd Cl A Ord Shs (ITOC:NASDAQ), 45.3%
- Aspire Biopharma Holdings, Inc. (ASBP:NASDAQ), 40.72%
- Paysign, Inc. (PAYS:NASDAQ), 36.6%
- TOP Financial Group Limited (TOP:NASDAQ), 35.51%
- Sarepta Therapeutics, Inc. (SRPT:NASDAQ), 34.98%
- FreeCast Inc. (CAST:NASDAQ), 34.03%